Breast Carcinomas with Equivocal HER2/Neu Amplification: Morphologic Features, CEP17 Polysomy and HER2 Genetic Heterogeneity

被引：0
|
作者：
Astvatsaturyan, K. [1 ]
Bose, S. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
LABORATORY INVESTIGATION | 2012年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
91
引用
收藏
页码：24A / 25A
页数：2
相关论文
共 50 条
  • [21] HER2/neu-Amplified Breast Cancers with HER2/CEP17 ratio ≥ 2.0 but with an Average HER2 Copy Number <4.0 Signals/Cell: An Assessment of Frequency, Immunohistochemical Correlation, and Clinicopathologic Features
    Zare, Somaye
    Lin, Leo
    Alghamdi, Abrar G.
    Roma, Andres
    Dell'Aquila, Marie
    Hasteh, Farnaz
    Fadare, Oluwole
    MODERN PATHOLOGY, 2018, 31 : 117 - 117
  • [22] The Clinical Utility of Alternative CEP17 Probes in Cases of Equivocal HER2 FISH Results
    Sanders, Mary Ann
    Martin, Alvin
    LABORATORY INVESTIGATION, 2015, 95 : 64A - 64A
  • [23] The Clinical Utility of Alternative CEP17 Probes in Cases of Equivocal HER2 FISH Results
    Sanders, Mary Ann
    Martin, Alvin
    MODERN PATHOLOGY, 2015, 28 : 64A - 64A
  • [24] HER2/neu-Amplified Breast Cancers with HER2/CEP17 ratio ≥ 2.0 but with an Average HER2 Copy Number <4.0 Signals/Cell: An Assessment of Frequency, Immunohistochemical Correlation, and Clinicopathologic Features
    Zare, Somaye
    Lin, Leo
    Alghamdi, Abrar G.
    Roma, Andres
    Dell'Aquila, Marie
    Hasteh, Farnaz
    Fadare, Oluwole
    LABORATORY INVESTIGATION, 2018, 98 : 117 - 117
  • [25] Chromosome 17 Polysomy: Correlation with Histological Parameters and HER2/Neu Gene Amplification
    Orsaria, M.
    Khelifa, S.
    Buza, N.
    Kamath, A.
    Hui, P.
    LABORATORY INVESTIGATION, 2012, 92 : 56A - 57A
  • [26] Chromosome 17 Polysomy: Correlation with Histological Parameters and HER2/Neu Gene Amplification
    Orsaria, M.
    Khelifa, S.
    Buza, N.
    Kamath, A.
    Hui, P.
    MODERN PATHOLOGY, 2012, 25 : 56A - 57A
  • [27] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
  • [28] Relationship between pathological features, HER2 protein expression and HER2 and CEP17 copy number in breast cancer: biological and methodological considerations
    Lambein, Kathleen
    Praet, Marleen
    Forsyth, Ramses
    Van den Broecke, Rudy
    Braems, Geert
    Matthys, Bart
    Cocquyt, Veronique
    Denys, Hannelore
    Pauwels, Patrick
    Libbrecht, Louis
    JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (03) : 200 - 207
  • [29] Assessments of HER2 Gene Status in Breast Carcinomas with Polysomy of Chromosome 17
    Gatalica, Z.
    Repertinger, S.
    Hatcher, L.
    Ulmer, P.
    MODERN PATHOLOGY, 2009, 22 : 41A - 41A
  • [30] Assessment of HER2 Gene Status in Breast Carcinomas With Polysomy of Chromosome 17
    Vranic, Semir
    Teruya, Bryan
    Repertinger, Susan
    Ulmer, Pamela
    Hagenkord, Jill
    Gatalica, Zoran
    CANCER, 2011, 117 (01) : 48 - 53
12345